Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial

Jens U Jensen, Lars Hein, Bettina Lundgren, Morten H Bestle, Thomas T Mohr, Mads H Andersen, Klaus J Thornberg, Jesper Løken, Morten Steensen, Zoe Fox, Hamid Tousi, Peter Søe-Jensen, Anne Ø Lauritsen, Ditte Strange, Pernille L Petersen, Nanna Reiter, Søren Hestad, Katrin Thormar, Paul Fjeldborg, Kim M LarsenNiels E Drenck, Christian Ostergaard, Jesper Kjær, Jesper Grarup, Jens D Lundgren, Procalcitonin And Survival Study (PASS) Group

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

338 Citationer (Scopus)

Abstract

For patients in intensive care units, sepsis is a common and potentially deadly complication and prompt initiation of appropriate antimicrobial therapy improves prognosis. The objective of this trial was to determine whether a strategy of antimicrobial spectrum escalation, guided by daily measurements of the biomarker procalcitonin, could reduce the time to appropriate therapy, thus improving survival.
OriginalsprogEngelsk
TidsskriftCritical Care Medicine
Vol/bind39
Udgave nummer9
Sider (fra-til)2048-58
Antal sider11
ISSN0090-3493
DOI
StatusUdgivet - 1 sep. 2011

Citationsformater